Replies to post #512244 on NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

Short Memory, the NASDAQ pushed them off the exchange. I was not Linda's first choice.
https://www.prnewswire.com/news-releases/nw-bio-announces-decision-to-voluntarily-withdraw-from-nasdaq-listing-and-begin-trading-on-otc-market-300374967.html

Due to the fact that the Nasdaq Staff has not accepted the Company's plan of remediation, the Nasdaq Staff would have issued a letter (the "Staff Determination") indicating that, unless the Company requested a hearing before an independent Nasdaq Listing Qualifications Panel (the "Panel") to review the Staff Determination, the Company's common stock would be subject to delisting from Nasdaq. If the Company requested such a hearing, it would likely have taken place in February, 2017. A request for a hearing would stay any suspension or delisting action pending the hearing and the expiration of any additional extension period granted by the Panel. The Panel would have the discretion to grant the Company an extension period of up to 180 calendar days from the date of the Staff Determination within which the Company would be required to demonstrate compliance with all applicable listing requirements.

In that regard, as previously announced on June 24, 2016, the Company is currently under a grace period for compliance with the $1.00 per share bid price requirement, as set forth in Listing Rule 5550(a)(2), which expires on December 21, 2016. The Company had planned to conduct a Special Meeting shortly after the upcoming Annual Meeting, to obtain shareholder approval for the reverse split and the plan of remediation proposed to the Nasdaq Staff. However, since the plan of remediation was not accepted, the Company is not currently proceeding with the Special Meeting or the reverse stock split.

Notwithstanding the right to a hearing before the Panel, there can be no assurance that the Panel would determine to maintain the listing of the Company on The Nasdaq Capital Market.

The Company's Board of Directors considered a variety of factors and reached a unanimous decision for the Company to voluntarily withdraw its listing on Nasdaq and undertake the actions necessary to trade on the OTCQB, rather than seeking to remain on Nasdaq and go through the hearing process.

The delay in holding he ASM is NWBO's hope that they will have some significant positive news to share with share holders when the do hold it IMHO. Lets hope they are right.

[hoffmann6383]

absolute nonsense. LP wants to, and will, be uplisted

[eagle8]

Do you really think that if L.P. set up a worldwide DCvax production network, brought in and developed a totally new automation system in a brilliant way, achieved great results in the trial with extensions to combo trials, established a platform for the treatment of many types of cancer in the future, has withstood the unbelievable attacks on the company,still managed to raise the funds to achieve the above results, do you really think she will forget to provide an uplist? I do not think so.
If you can count, count on it.

GL

[kabunushi]

What really matters to investors is getting Dc-vax approved. We know that you deny that is possible, fine, everyone is entitled to their opinion. We believe that is coming and a lot sooner than you think. When that happens we will have very outsized gains relative to .25 cost basis or .70 cost basis and well worth the wait even for those who have been holding for 5 years. At .25 cost basis even .75 is a very decent 3x return even if it took 5 years. But I'm sure the likely return even to those who sell early can probably get another 3x from here.

We shall see and I think much sooner than you can possibly imagine.